Phoenix PharmaLabs Strengthens its Position as a Developer of Next Generation Pain Pharmaceuticals with the Acquisition of a Portfolio of NOP/Mu Agonist Compounds
Tuesday, January 5th 2021 at 2:05pm UTC SALT LAKE CITY–(BUSINESS WIRE)– Phoenix PharmaLabs, a privately-held pre-clinical drug discovery company dedicated…